Similarly, CYP4F3 and CYP20A1 were prominently expressed in advanced-stage HNSCC patient biopsies, indicating that the tumour microenvironment may upregulate these isoforms to support cancer progression. The gene discussed is CYP4F3; the disease is cancer.